Skip to content
Education Training, Medical Health Aged Care

Growing myopia concerns ahead of 2025 school year

22 January, 2024 3 mins read

Optometrists are urging parents to add eye tests to their back-to-school checklist amidst new data from Bupa Optical revealing that 27 per cent of children who underwent an eye test in 2024 were found to be Myopic.

 

These figures represent an alarming contrast to figures from the 2010s, with a separate survey from the Child Myopia Working Group suggesting just 15 per cent of parents in Australia had a child diagnosed with Myopia in 2018. This was prior to the COVID-19 pandemic when time spent in front of screens surged, potentially contributing to permanent eye issues.

 

Bupa Optical Optometrist Karen Makin said today’s children are far more likely to live with myopia than ever before as we continue to scratch the surface of the long-term effects of lockdowns, homeschooling and increased device usage.

 

“Unfortunately, we are seeing more and more parents telling us their children used to have perfect eyesight but are now squinting or having difficulty concentrating in class.

 

“This is part of a concerning trend of kids spending increased time in front of screens and less time playing outdoors exposed to natural light which can help reduce the risk of developing myopia or help to slow down the progression of myopia. Mobile phones are a particular concern as they tend to be held closer to the face meaning the eyes are continually focusing at a close distance, not varying their focus from one distance to another,” Karen said.

 

Myopia can often be attributed to genetics however lifestyle factors such as screen time, physical activity and even diet play a major role in the development of healthy eyes, particularly for children whose bodies are still growing.

 

“A child’s eyesight can change very quickly which means annual eye tests are a great way to track any emerging issues and address them before they start to impact their schooling or general development.

 

“Unlike many physical conditions, vision impairments can be difficult for a parent to identify, however there are some tell-tale signs a parent can take note of, such as squinting, watery eyes or just general tiredness or irritability,” Karen said.

 

The latest data from the Child Myopia Working Group in 2022 suggests that around 30 per cent of children under 18 have never had an eye test, which means there is likely to be a large number of undiagnosed childhood cases of Myopia in Australia.

 

“With cost-of-living pressures affecting many families, it’s important to remember that eye tests are bulk-billed for eligible Medicare card holders at Bupa Optical, are quick and a lot less hassle than those constantly changing lunchbox requests!” Karen said.



 

ENDS

 

Editors note:

 

Karen Makin, Optometrist at Bupa Optical is available for interview.

 

For more information or interview requests, please contact:

 

Eli Grynberg                                                   
External Communications Manager, Bupa                             
Email:
[email protected]     

Mob: 0401 135 713                                                       

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 7.3 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 22,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Over the past 17+ years we have invested more than AUD$36 million in partnerships and programs focused on improving health of communities across Australia.



 

 


Contact details:

Eli Grynberg                                                   
External Communications Manager, Bupa                             
Email:
[email protected]     

Mob: 0401 135 713   

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.